首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats.
【24h】

Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats.

机译:自发性高血压大鼠在雌激素缺乏期间的内皮功能障碍和氧化应激。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Postmenopausal estrogen deficiency is associated with an increased cardiovascular risk, hypertension, and oxidative stress. Angiotensin type 1 (AT(1)) receptor regulation is involved in the pathogenesis of atherosclerosis. To characterize vascular function, oxidative stress, and AT(1) receptor regulation during estrogen deficiency, ovariectomized spontaneously hypertensive rats (SHR) were investigated in comparison with sham-operated animals and with ovariectomized rats receiving estrogen replacement therapy with 17beta-estradiol. METHODS AND RESULTS: Arterial blood pressure was similar in all 3 groups investigated. Five weeks after ovariectomy, endothelial dysfunction in aortic rings was observed, which was reversed by estrogen replacement therapy. Estrogen deficiency led to an enhanced vasoconstriction by angiotensin II. Vascular superoxide production was significantly increased compared with that in sham-operated rats, as measured by lucigenin chemiluminescence assays. Estrogen substitution normalized the production of free radicals in the vessel wall. Vascular AT(1) receptor expression was significantly upregulated by estrogen deficiency, as shown by quantitative reverse transcription-polymerase chain reaction, whereas endothelial NO synthase mRNA expression and NO release were unchanged. Five-week treatment of the animals with the AT(1) receptor antagonist irbesartan prevented endothelial dysfunction in ovariectomized rats and normalized the vascular production of free radicals. CONCLUSIONS: In SHR, estrogen deficiency leads to increased vascular free radical production and enhanced angiotensin II-induced vasoconstriction via increased vascular AT(1) receptor expression, resulting in endothelial dysfunction. Estrogen replacement therapy and AT(1) receptor antagonism prevent these pathological changes. Therefore, estrogen deficiency-induced AT(1) receptor overexpression and oxidative stress may play an important role in cardiovascular diseases associated with menopause.
机译:背景:绝经后雌激素缺乏与心血管风险增加,高血压和氧化应激有关。 1型血管紧张素(AT(1))受体调节参与动脉粥样硬化的发病机理。为了表征雌激素缺乏期间的血管功能,氧化应激和AT(1)受体调节,与假手术动物和接受17β-雌二醇替代雌激素替代治疗的去卵巢大鼠进行了比较,研究了去卵巢自发性高血压大鼠(SHR)。方法和结果:在所有调查的三组中,血压均相似。卵巢切除术后五周,观察到主动脉环内皮功能障碍,雌激素替代疗法可逆转此现象。雌激素缺乏导致血管紧张素II增强了血管收缩。通过发光素化学发光法测定,与假手术大鼠相比,血管中超氧化物的产生显着增加。雌激素取代使血管壁中自由基的产生正常化。如定量逆转录-聚合酶链反应所示,雌激素缺乏可显着上调血管AT(1)受体的表达,而内皮NO合酶mRNA的表达和NO的释放均未改变。用AT(1)受体拮抗剂厄贝沙坦对动物进行的五周治疗可防止卵巢切除大鼠的内皮功能障碍,并使自由基的血管生成正常化。结论:在SHR中,雌激素缺乏会导致血管自由基产生增加,并通过增加血管AT(1)受体的表达而增强血管紧张素II诱导的血管收缩,从而导致内皮功能障碍。雌激素替代疗法和AT(1)受体拮抗作用可防止这些病理变化。因此,雌激素缺乏诱导的AT(1)受体过表达和氧化应激可能在与绝经有关的心血管疾病中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号